The 2nd Wnt/B-Catenin Pathway Targeted Drug Development Summit is focused on how to translate structural biology into clinical development, and overcome the safety and toxicity concerns.
The 2nd Wnt/B-Catenin Pathway Targeted Drug Development Summit covers topics such as:
- Investigating Wnt Mechanisms of Action to Inform Novel Drug Development
- Relating Wnt & β-Catenin Biology to Drug Discovery Lessons Learned Today
- Characterizing Novel Targets for Preclinical Development
- Lessons Learned in Wnt Pathway Discoveries & Advancements Made
- Future Wnt & B-Catenin Target Strategies & Bottleneck’s in the Clinic & Beyond
- Clinical Updates of Wnt/β-Catenin – How Can We Successfully Drug this Target in Clinic?
The 2nd Wnt/B-Catenin Pathway Targeted Drug Development Summit brings together Wnt/β-catenin drug developers.
